ArticleOncology letters2022

miR-29b-3p inhibits 22Rv1 prostate cancer cell proliferation through the YWHAE/BCL-2 regulatory axis.

Jiafu Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.